Skip to Main Content
Jenny Riecke, M.D.

Jenny Riecke, M.D.

Assistant Professor

School
Medical School
Department
Neurology | Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    • Joined UT Southwestern: 2023
    • Clinical Interests: Dr. Riecke specializes in diagnosing and treating neuromuscular disorders with a special interest in Myasthenia Gravis. She also specializes in palliative care for progressive neurologic disorders. In this role she addresses management of symptoms related to neurodegenerative diseases and also helps patients and families with complex medical decisions and advance care planning.
    • Research: Dr. Riecke is interested in the factors that affect medical decision making in patients with ALS, including how socioeconomic and cultural factors affect these decisions.
    • Education: Dr. Riecke is active in medical student, resident, and fellow education and is a member of the Clinical Competency and Program Evaluation Committees for the Neurology Residency and Neuromuscular Medicine Fellowship programs. 
    • Special Roles/ Leadership: Dr. Riecke started a faculty clinic for patients with ALS at Parkland with the goal of providing subspecialty care to unfunded and underfunded patients.

  • Education
    Medical School
    McGovern Medical School at the University of Texas Health Science Center at Houston (2017)
    Internship
    UT Southwestern Medical School (2020)
    Residency
    UT Southwestern Medical Center (2021), Neurology
    Fellowship
    UT Southwestern Medical Center (2022), Neuromuscular Disease
    Fellowship
    UT Southwestern Medical Center (2023), Palliative Care
  • Publications
    Futility and Shared Decision-Making
    Rubin MA, Riecke J, Heitman E Neurologic Clinics 2023 Aug 41 455-467
    Port-Wine Stain and Monomelic Weakness Associated with Perineurioma: A Neuromuscular Image
    Riecke J, Chhabra A, Burns D, Trivedi JR Journal of Clinical Neuromuscular Disease 2022 Mar 23 156-159
    World-wide efficacy of bone marrow derived mesenchymal stromal cells in preclinical ischemic stroke models: Systematic review and meta-analysis
    Satani N, Cai C, Giridhar K, McGhiey D, George S, Parsha K, Nghiem DM, Valenzuela KS, Riecke J, Vahidy FS, Savitz SI Frontiers in Neurology 2019 10
    A Meta-Analysis of Mesenchymal Stem Cells in Animal Models of Parkinson's Disease
    Riecke J, Johns KM, Cai C, Vahidy FS, Parsha K, Furr-Stimming E, Schiess M, Savitz SI Stem Cells and Development 2015 Sep 24 2082-2090